Sell Johnson & Johnson After Vaccine Halt? See This Chart First

Sell Johnson & Johnson After Vaccine Halt? See This Chart First


Johnson & Johnson  (JNJ) – Get Report shares were down about 2.5% on Tuesday, coming under pressure after the Centers for Disease Control and the Food and Drug Administration “suspended use of the drugmaker’s coronavirus vaccine” amid concerns of blood-clotting cases.

Leave a comment